Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified. more
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | -1.88% | 0.01% |
| 1-Month Return | 10.82% | 3.54% |
| 3-Month Return | 5.38% | 10.58% |
| 6-Month Return | -7.3% | 8.03% |
| 1-Year Return | 26.66% | 20.06% |
| 3-Year Return | 30.55% | 70.98% |
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | -62.83% | 0.52% |
| 1-Month Return | 249.02% | 52.69% |
| 3-Month Return | 23.68% | 50.36% |
| 6-Month Return | -14.25% | 16.96% |
| 1-Year Return | 26.66% | 20.06% |
| 3-Year Return | 9.29% | 19.58% |
| Stock name | Ticker | Weight |
|---|---|---|
Novo Nordisk A/S
|
NVO |
13.12%
|
Eli Lilly & Co
|
LLY |
12.32%
|
Pfizer Inc
|
PFE |
6.28%
|
CSPC Pharmaceutical Group Ltd
|
1093.HK |
6.05%
|
Viking Therapeutics Inc
|
VKTX |
5.72%
|
Kailera Therapeutics Inc
|
KLRA |
5.72%
|
Ascletis Pharma Inc
|
1672.HK |
4.34%
|
Chugai Pharmaceutical Co Ltd
|
4519.T |
4.33%
|
Amgen Inc
|
AMGN |
3.78%
|
Zealand Pharma A/S
|
ZEAL.CO |
3.74%
|
Hanmi Pharm Co Ltd
|
128940.KS |
3.46%
|
AstraZeneca PLC
|
AZN |
3.4%
|
MBX Biosciences Inc
|
MBX |
3.04%
|
Roche Holding AG
|
ROP.SW |
2.99%
|
Structure Therapeutics Inc
|
GPCR |
2.98%
|
United Laboratories International Holdings Ltd/The
|
3933.HK |
2.78%
|
Hansoh Pharmaceutical Group Co Ltd
|
3692.HK |
2.68%
|
Innovent Biologics Inc
|
1801.HK |
2.6%
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
|
1276.HK |
2.59%
|
Gubra A/S
|
GUBRA.CO |
2.03%
|
Gilead Sciences Inc
|
GILD |
1.75%
|
Rhythm Pharmaceuticals Inc
|
RYTM |
1.56%
|
Shionogi & Co Ltd
|
4507.T |
1.22%
|
WaVe Life Sciences Ltd
|
WVE |
0.91%
|
First American Government Obligations Fund 12/01/2031
|
FGXXX |
0.66%
|
Cash & Other
|
Cash...Other |
0.36%
|
SWISS FRANC
|
CHF |
-0.42%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
Roundhill Glp-1 & Weight Loss ETF (OZEM) share price today is $33.12.
Yes, Indians can buy shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. To buy OZEM from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. You can start investing in Roundhill Glp-1 & Weight Loss ETF (OZEM) with a minimum investment of $1.
The 52-week high price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $37.15. The 52-week low price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $22.95.
The stock symbol (or ticker) of Roundhill Glp-1 & Weight Loss ETF is OZEM.
Yes, you can setup SIP in Roundhill Glp-1 & Weight Loss ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of OZEM on the Vested app.
The expense ratio of Roundhill Glp-1 & Weight Loss ETF (OZEM) is 0.59%.
Link copied